Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03680066
Other study ID # CCER 2017-01413
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date April 1, 2018
Est. completion date November 28, 2023

Study information

Verified date November 2023
Source University Hospital, Geneva
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This protocol will help better define whether patients with peanut and/or tree nut food allergy can tolerate traces in products with precautionary allergen labelling.


Description:

Visit 1 (V1): During this visit at the Pediatric Research Platform at the Children's Hospital, subjects will undergo an open food challenge to 3 processed foods labeled with "may contain traces" by following safety and accuracy guidelines for food challenges (7). The following foods (similar for all patients) will be given in one dose in the size of a regular serving: - cookies, max 30 g; - chocolate, max 30 g; - breakfast cereals, max 50 g. Each meal will be administered with a 1 hour observation period in between and at the end. If the patient does not react to any of the foods or has only oral itching (mild symptoms), he/she will be instructed to stop the ban on "may contain" foods and eat them regularly. If the patient has more than mild symptoms, the study will be stopped and the patient will be banned from eating foods with traces. The study subjects with a negative challenge and instructed to eat foods with the "may contain" label will be provided emergency medications and instruction on when and how to use them according to current guidelines (8). An age appropriate quality of life questionnaire will be filled out by the parents/patient during the visit. For the following 3 months after "may contain food" challenges, the patients will be invited to eat on a regular basis any foods labeled as "may contain" tree nuts and/or peanuts and record the consumption on a diary. Such foods will only be eaten in presence of a family member instructed for the measures to be taken in case of a reaction. They will record any history of reaction and contact the study team. The brand name of the food, and if available the batch will be recorded. The participants will store the study food and its packaging safely in a box and bring it along at V2 for allergen content analysis. If a reaction occurs, the food will be analyzed for allergen content by immunoaffinity capillary elecrophoresis-matrix assisted laser desorption/ionization mass spectrometry, as well as a simplified version of this technique, the immunomagnetic separation -matrix-assisted laser desorption/ionization mass spectrometry. Visit 2 (V2): During this visit, the parents/patients will report on the brand, the frequency and the amount of "may contain" foods eaten since V1. The quality of life questionnaire will be filled out again by the parents/patient.


Recruitment information / eligibility

Status Terminated
Enrollment 15
Est. completion date November 28, 2023
Est. primary completion date November 28, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 18 Years
Eligibility Inclusion Criteria: - Children aged 2-18 years at time of inclusion - Tree nut or peanut allergy documented by: - Positive skin prick tests (SPTs) to peanut and/or tree nuts - Positive specific IgE (sIgE) to peanut and/or tree nuts ( =0.35 kU/L) - A recent (< 1 year) positive food challenge, reacting to the dose of 30 mg of proteins or below. - Parent/Legal guardian has been informed about the study and has signed Informed Consent Form Exclusion Criteria: - History of a moderate or severe reaction during a food challenge with a dose of 30 mg of proteins or less. - Expected non-adherence to the study protocol. - Severe or uncontrolled asthma.

Study Design


Intervention

Other:
Oral food challenge to foods with traces
Subjects will undergo an open food challenge to 3 processed foods labeled with "may contain traces". The following foods (similar for all patients) will be given in one dose in the size of a regular serving: cookies, max 30 g; chocolate, max 30 g; breakfast cereals, max 50 g. Each meal will be administered with a 1 hour observation period in between and at the end.

Locations

Country Name City State
Switzerland Pediatric Allergy Unit - University Hospitals of Geneva Geneva

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Geneva

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Result of the food challenges with foods labelled with "may contain traces" (tolerated or reacted). Result of the food challenges with foods labelled with "may contain traces" (tolerated or reacted). At study entry
Secondary Tolerance to foods labelled with "may contain traces" eaten normally during a 3 months follow-up. Tolerance to foods labelled with "may contain traces" eaten normally during a 3 months follow-up (reactions / no reactions to these foods). During 3 months follow-up
Secondary Frequency of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up. Frequency of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up (number of reactions). During 3 months follow-up
Secondary Severity of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up. Severity of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up (severity of reactions by reaction type). During 3 months follow-up
Secondary Changes of quality of life after 3 months without restriction of foods labelled with "may contain traces", compared to baseline when restricting. Changes of quality of life measured with the age-appropriate "Food allergy quality of life questionnaire (0-12 years [parents], 7-12 years [patients], or 13-17 years [patients]. Results (on a continuous numerical ranking from 1 to 6 for each item) after 3 months without restriction of foods labelled with "may contain traces", are compared to baseline when restricting. At entry and after 3 months
See also
  Status Clinical Trial Phase
Withdrawn NCT03089476 - Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy N/A
Recruiting NCT05839405 - Food Allergy in the Brain
Completed NCT02552537 - iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions Phase 4
Completed NCT01634737 - Crustacean Allergy and Dust Mites Sensitization N/A
Recruiting NCT05521711 - TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation N/A
Completed NCT05072665 - Fast Allergy Sensitivity Test N/A
Active, not recruiting NCT04887441 - Allergology: Information, Data and Knowledge Organization
Recruiting NCT03265262 - The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy N/A
Completed NCT04186949 - Early Origins of Allergy and Asthma
Completed NCT02490007 - Pertussis Immunisation and Food Allergy
Recruiting NCT03151252 - Improvement of Foodallergy Diagnostic in Gastrointestinal Tract N/A
Completed NCT02159833 - Intranasal Diagnostics in Food Allergy: a Feasibility Study N/A
Completed NCT02377284 - Prevention and Management of Food Allergies N/A
Completed NCT02354729 - Encouraging Allergic Young Adults to Carry Epinephrine N/A
Completed NCT02640560 - One-year Survey of Anaphylaxis in Outpatient Children Allergic to Peanuts, Walnuts/Hazelnuts, Shellfish N/A
Enrolling by invitation NCT06097572 - Improved Diagnostics in Food Allergy Study N/A
Recruiting NCT04606615 - Skin Barrier Abnormalities and Oxidative Stress Response
Recruiting NCT05785299 - Clinical Versus Home Introduction of Milk in Children With Non-IgE-mediated Cow's Milk Allergy N/A
Not yet recruiting NCT06112873 - Quality of Life in Food Allergy: Validation of Three Mini-questionnaires
Completed NCT03337802 - Effect of Mediterranean Diet During Pregnancy on the Onset of Overweight and Obesity in the Offspring N/A